NASDAQ:BMRN Investor Notice: Lawsuit Alleges Misleading Statements by BioMarin Pharmaceutical Inc.
An investor, who purchased NASDAQ:BMRN shares, filed a lawsuit against BioMarin Pharmaceutical Inc. over alleged violations of Federal Securities Laws.
View full press release